XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 75.97% | 5.58% | -2.75% | 17.61% | 1.09% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 31.12% | -18.03% | -14.88% | 9.58% | 13.23% |
| Operating Income | -31.12% | 18.03% | 14.88% | -9.58% | -13.23% |
| Income Before Tax | -17.48% | 11.33% | 19.14% | -29.58% | -58.60% |
| Income Tax Expenses | 834.38% | 231.11% | -88.04% | -109.18% | -113.17% |
| Earnings from Continuing Operations | -18.19% | 10.72% | 19.55% | -28.20% | -56.90% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.19% | 10.72% | 19.55% | -28.20% | -56.90% |
| EBIT | -31.12% | 18.03% | 14.88% | -9.58% | -13.23% |
| EBITDA | -32.60% | 18.82% | 15.57% | -9.95% | -13.87% |
| EPS Basic | -18.09% | 10.80% | 19.62% | -28.08% | -56.79% |
| Normalized Basic EPS | -18.82% | 11.41% | 19.22% | -29.46% | -58.51% |
| EPS Diluted | -18.09% | 11.06% | 19.85% | -27.33% | -55.63% |
| Normalized Diluted EPS | -18.82% | 11.41% | 19.22% | -29.46% | -58.51% |
| Average Basic Shares Outstanding | 0.09% | 0.09% | 0.11% | 0.10% | 0.07% |
| Average Diluted Shares Outstanding | 0.09% | 0.09% | 0.11% | 0.10% | 0.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |